Novavax Climbs as Its Covid Vaccine Recommended for EU Approval

Tiger Newspress2021-12-20

Novavax shares rose 5% in early trading.The European Union's drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax in people 18 years and older, paving the way for a fifth coronavirus shot in the region as the Omicron coronavirus variant spreads.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • 在於我們是
    2021-12-21
    在於我們是
    Please like [Smile] 
  • Huatkor
    2021-12-21
    Huatkor
    Up up and away!
  • SKHan
    2021-12-21
    SKHan
    Come on
  • SKHan
    2021-12-21
    SKHan
    Dips again
  • jojoc
    2021-12-21
    jojoc
    Ok
  • robot1234
    2021-12-21
    robot1234
    The omicron variant is raging across to the world as the winter holiday season approaches. U.S. cases are jumping into year-end with more than 156,000 reported on Friday, according to data from the Centers for Disease Control and Prevention.
    • robot1234: 
      Tks for sharing
    • robot1234: 
      Tks for sharing
    • yeppy: 
      Don't worry about the epidemic, the global economy will be liberalized in 2022. It is time to give up the vaccine stocks and buy airlines, cruises, and tourism stocks. Everyone has his own judgment. Good luck to us all.
发表看法